The investigational drug in this study is being developed for the potential treatment of atopic dermatitis (AD). The purpose of this study is to look at how much of the study drug gets into the blood stream and how long the body takes to get rid of it after subcutaneous (under the skin) injections using a pre-filled syringe with needle safety device and an autoinjector.
Group 7 Check-In: Aug 4
Check-Out: Aug 5
Outpatient Visits: Aug 7, 9, 12, 15, 19, 26, Sep 2, 16, 30, Oct 14, 28, Nov 11
Phone Call: Sep 9, 23, Oct 7